NAM CROs & testing servicesconfirmed
Crown Bioscience
Oncology CRO offering patient-derived organoids, PDX models, ex vivo tissue platforms and biomarker work.
Notable
Ninth member of C-Path's NAMs Developer Coalition (Jul 2026).
Related deals
No tracked deals yet.
Related updates
- Jul 16, 2026Crown Bioscience joins C-Path's NAMs Developer Coalitionc-path.org(opens in new tab)